CINECA IRIS Institutional Research Information System

MARCOCCI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.943
AS - Asia 16.138
EU - Europa 11.341
SA - Sud America 2.677
AF - Africa 784
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 17
Totale 63.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.048
SG - Singapore 4.927
CN - Cina 4.281
IT - Italia 3.266
HK - Hong Kong 2.854
BR - Brasile 2.219
SE - Svezia 2.057
VN - Vietnam 1.539
DE - Germania 1.127
BG - Bulgaria 1.051
GB - Regno Unito 681
TR - Turchia 669
CA - Canada 659
FR - Francia 644
RU - Federazione Russa 530
FI - Finlandia 520
UA - Ucraina 478
KR - Corea 386
AT - Austria 377
IN - India 366
CI - Costa d'Avorio 273
JP - Giappone 219
CH - Svizzera 178
BD - Bangladesh 158
AR - Argentina 146
SN - Senegal 125
IQ - Iraq 109
ZA - Sudafrica 97
MX - Messico 95
ID - Indonesia 92
SA - Arabia Saudita 82
EC - Ecuador 81
NL - Olanda 81
PK - Pakistan 70
UZ - Uzbekistan 69
PL - Polonia 63
MA - Marocco 61
BE - Belgio 57
CO - Colombia 57
VE - Venezuela 56
ES - Italia 50
EG - Egitto 47
NG - Nigeria 44
KE - Kenya 39
PH - Filippine 32
PY - Paraguay 32
JO - Giordania 29
DZ - Algeria 28
CL - Cile 25
NP - Nepal 25
CZ - Repubblica Ceca 24
AU - Australia 21
JM - Giamaica 21
UY - Uruguay 21
AZ - Azerbaigian 20
DO - Repubblica Dominicana 20
IE - Irlanda 20
MY - Malesia 20
IL - Israele 19
PE - Perù 19
AE - Emirati Arabi Uniti 18
LB - Libano 18
BO - Bolivia 16
CR - Costa Rica 16
PS - Palestinian Territory 15
RO - Romania 15
TN - Tunisia 14
GR - Grecia 13
KZ - Kazakistan 13
LT - Lituania 13
TH - Thailandia 13
TT - Trinidad e Tobago 13
AL - Albania 12
BB - Barbados 12
ET - Etiopia 12
EU - Europa 12
HU - Ungheria 11
KG - Kirghizistan 11
LV - Lettonia 11
OM - Oman 11
RS - Serbia 11
HN - Honduras 9
IR - Iran 9
NI - Nicaragua 9
PA - Panama 9
BJ - Benin 8
DK - Danimarca 8
GE - Georgia 8
PT - Portogallo 8
BS - Bahamas 7
SK - Slovacchia (Repubblica Slovacca) 7
BH - Bahrain 6
KW - Kuwait 6
QA - Qatar 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BW - Botswana 5
CG - Congo 5
EE - Estonia 5
GT - Guatemala 5
Totale 63.816
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.472
Ashburn 3.249
Hong Kong 2.813
Fairfield 2.769
Singapore 2.668
Houston 2.116
Ann Arbor 2.069
Chandler 1.739
Dallas 1.696
San Jose 1.523
Santa Clara 1.472
Seattle 1.162
Sofia 1.050
Wilmington 996
Shanghai 980
Cambridge 925
Beijing 887
Milan 871
New York 763
Jacksonville 542
Ottawa 516
Boardman 513
Serra 511
Hefei 497
Princeton 462
Los Angeles 451
Lawrence 433
Medford 393
Ho Chi Minh City 387
Seoul 371
Lauterbourg 355
Vienna 330
Nanjing 293
Izmir 281
Abidjan 273
Hanoi 273
Des Moines 268
Istanbul 251
Munich 246
Florence 229
Dearborn 208
Dong Ket 205
Tokyo 200
São Paulo 177
London 172
Buffalo 167
San Diego 157
Redondo Beach 155
Bern 153
Frankfurt am Main 150
Helsinki 131
Dakar 122
Nanchang 120
Rome 115
Jüchen 113
Pisa 109
Bremen 97
Council Bluffs 91
Lancaster 85
Redwood City 84
Ogden 80
Orem 73
Rio de Janeiro 73
Düsseldorf 71
Kunming 69
Chicago 67
Marseille 66
Turku 64
Boulder 63
Hebei 61
Shenyang 61
Tashkent 61
Columbus 60
Da Nang 60
The Dalles 58
Changsha 56
Brussels 54
Piscataway 54
Norwalk 53
Washington 50
Belo Horizonte 47
Brooklyn 46
Kocaeli 46
Fuzhou 45
Tianjin 45
Baghdad 44
Guangzhou 43
Haiphong 43
Johannesburg 42
Phoenix 42
San Francisco 42
Dhaka 41
Montreal 40
Atlanta 38
Falls Church 38
Hyderabad 37
Jiaxing 37
Nuremberg 36
Lagos 35
Warsaw 34
Totale 45.981
Salva come PNG Salva come JPEG
Nome #
Complicanze chirurgiche in pazienti sottoposti a decompressione orbitaria per oftalmopatia di Graves [Surgical complications in orbital decompression for Graves’ orbitopathy] 454
Thyroid directed antibodies 366
Natural history of graves’ orbitopathy after treatment 265
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 243
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 236
Primary hyperparathyroidism 235
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 229
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial 227
1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth 226
Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis 225
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone 224
Sortilin is a putative post-endocytic receptor of thyroglobulin 224
Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency 223
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 222
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 222
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 219
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation. 217
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer 215
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 214
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 214
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 208
A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1 207
A proteomic approach to study parathyroid glands 205
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas 205
Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells 203
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 203
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 203
Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin 202
Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism 202
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy 200
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 200
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 200
Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST 199
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 199
Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I 198
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 198
More on smoking habits and Graves' ophthalmopathy 197
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease 197
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. 197
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 197
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center 197
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 196
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 194
TSH-Dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells 193
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 193
Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cells 191
Hereditary hypercalcemia caused by a homozygous pathogenic variant in the cyp24a1 gene: A case report and review of the literature 191
Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells 190
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 190
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 190
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 188
Six novel MEN1 gene mutations in sporadic parathyroid tumors 188
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 187
Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO) 187
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 187
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement 187
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 186
Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women 184
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with graves’ ophthalmopathy 184
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 184
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 183
Thyroid imaging in the management of anti-PD1/PD-L1 induced thyrotoxicosis 182
Demonstration and organ distribution of the 1,25-dihydroxyvitamin D3-binding protein in fish (A. anguilla) 181
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation 181
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 180
Whole exome sequencing in familial isolated primary hyperparathyroidism 180
Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism 179
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 178
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 178
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 177
Direct Determination of Tetrahydrocortisol and Tetrahydrocortisone in Urine Samples from Patients under Steroid Drugs Treatment by LC-MS-MS 176
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye 176
THERAPEUTIC CONTROVERSIES. RADIOIODINE MAY BE BAD FOR GRAVES’ OPHTHALMOPATHY , BUT…… 175
Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited 175
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 175
Come definire lo status della vitamina 25OHD: aspetti metodologici (laboratorio) e clinici (VDBP, free 25OHD, bioavailable 25(OH)D) 175
Risk factors for renal calcifications and determinants of hypercalciuria in patients with chronic, post-surgical hypoparathyroidism 175
Chirurgia dello strabismo nella oftalmopatia endocrina. 174
Studies on the occurrence of ophthalmopathy in Graves' disease 173
a novel germline mutation of men 1 gene in a patient with acromegaly and multiple endocrine tumors 173
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 173
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 173
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 173
Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices 172
Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated 172
The PRIMARA study: A prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice 172
Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene 172
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 172
Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? 171
A treatment strategy for Graves' orbitopathy 171
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 171
No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas 171
Clinical presentation and management of patients with primary hyperparathyroidism in Italy 171
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders 170
Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why 170
Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy 170
Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses 170
Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism 170
Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy 170
Totale 19.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.166
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 0 0 0 0 0 0 502
2021/20224.941 80 251 119 376 919 653 124 237 324 312 274 1.272
2022/20235.791 727 746 430 433 650 770 47 453 1.058 29 387 61
2023/20243.935 494 415 545 219 561 708 163 138 54 28 197 413
2024/202513.330 66 502 188 698 1.211 1.155 1.077 766 1.400 1.781 1.500 2.986
2025/202615.176 1.107 2.109 2.181 1.735 1.386 1.303 1.982 682 727 1.269 474 221
Totale 64.625